9 Jul 2012 16:35
Omega Diagnostics Group plc ("Omega" or "the Company")
Director Shareholding
Omega Diagnostics Group plc (AIM:ODX), the AIM listed medical diagnostics company, announces that Andrew Shepherd, Chief Executive of the Company, has increased his total beneficial holding following a purchase today of 600,000 ordinary shares in the Company at 16.5p per share, in the name of his wife Mrs Sharon Shepherd. Following this transaction Andrew Shepherd's total beneficial holding has increased to 2,618,030 ordinary shares representing 3.07 per cent of the issued ordinary share capital of the Company.
- Ends -
Enquiries:
Omega Diagnostics Group plc | Tel: 01259 763 030 |
Andrew Shepherd, Chief Executive | |
Kieron Harbinson, Group Finance Director | |
www.omegadiagnostics.com |
Seymour Pierce Limited (Nominated Adviser and Broker) | Tel: +44 (0) 20 7107 8000 |
Freddy Crossley | |
Corporate Broking | |
David Banks / Katie Ratner | |
www.seymourpierce.com |
Walbrook PR Limited | |
Paul McManus | Tel: 020 7933 8787 |
Mob: 07980 541 893 | |
paul.mcmanus@walbrookpr.com |
ODX.L (ODX)